Artificial intelligence: A tool for solving questions about cancer

December 9, 2016

UNC Lineberger recently partnered with IBM Watson to study whether the technology platform’s ability to “read,” analyze large amounts of big data, and generate evidence-based clinical recommendations could have a clinical role. The research findings are promising, and Hal McAdams is thankful that Watson found a treatment for his bladder cancer after others had failed him.

Cancer: It’s all in the genes

December 9, 2016

Beth Silverstein’s family history of cancer led her to UNC Lineberger’s Cancer Genetics Program. She learned she had a BRCA1 gene mutation that put her at an 80 percent risk of developing breast cancer and a 50 percent risk of ovarian cancer. Though not the news she wanted, she said the information has helped her take control of her health.

Fox fights bone marrow cancer and wins

December 9, 2016

Superior Court Judge Carl Fox, who was was diagnosed with myelodysplastic syndrome (MDS), a form of bone marrow cancer, in 2015. Thanks to the care of Josh Zeidner, MD, and Thomas Shea, MD, and a life-saving cord blood transplant, he is back on the bench.

Clinical trials lead to new treatments

December 9, 2016

When Amy Charney was diagnosed with HER-2 positive breast cancer in November 2014, she told Lisa Carey, MD, she preferred a therapy that would allow her to continue her active life as a mom, wife and avid runner. Dr. Carey identified a clinical trial for Amy was eligible, and is happy to report the novel treatment proved to be effective and have fewer side-effects.

Immunotherapy: Breaking barriers, beating cancer

December 9, 2016

Janet Mazzurco was diagnosed with melanoma seven years ago, which later developed into stage IV metastatic disease. Fran Collichio, MD, began treating Janet with a checkpoint inhibitor drug called ipilimumab and her disease is now in remission.

Artificial intelligence: A tool for solving questions about cancer

December 9, 2016

UNC Lineberger recently partnered with IBM Watson to study whether the technology platform’s ability to “read,” analyze large amounts of big data, and generate evidence-based clinical recommendations could have a clinical role. The research findings are promising, and Hal McAdams is thankful that Watson found a treatment for his bladder cancer after others had failed him.

Cancer: It’s all in the genes

December 9, 2016

Beth Silverstein’s family history of cancer led her to UNC Lineberger’s Cancer Genetics Program. She learned she had a BRCA1 gene mutation that put her at an 80 percent risk of developing breast cancer and a 50 percent risk of ovarian cancer. Though not the news she wanted, she said the information has helped her take control of her health.

Fox fights bone marrow cancer and wins

December 9, 2016

Superior Court Judge Carl Fox, who was was diagnosed with myelodysplastic syndrome (MDS), a form of bone marrow cancer, in 2015. Thanks to the care of Josh Zeidner, MD, and Thomas Shea, MD, and a life-saving cord blood transplant, he is back on the bench.

Clinical trials lead to new treatments

December 9, 2016

When Amy Charney was diagnosed with HER-2 positive breast cancer in November 2014, she told Lisa Carey, MD, she preferred a therapy that would allow her to continue her active life as a mom, wife and avid runner. Dr. Carey identified a clinical trial for Amy was eligible, and is happy to report the novel treatment proved to be effective and have fewer side-effects.

Immunotherapy: Breaking barriers, beating cancer

December 9, 2016

Janet Mazzurco was diagnosed with melanoma seven years ago, which later developed into stage IV metastatic disease. Fran Collichio, MD, began treating Janet with a checkpoint inhibitor drug called ipilimumab and her disease is now in remission.